Presurgical Phase IIB Trial of Oral CDB-4124 vs. Placebo in Women with Stage 0-II Primary Breast Cancer: PACT-B (Progesterone Antagonists for Cancer Treatment for Breast) Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Telapristone (Primary)
- Indications Breast cancer; Early breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 21 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2018 as reported by ClinicalTrials.gov record.
- 20 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.